First of two parts
暂无分享,去创建一个
[1] J. Sear,et al. Myocardial Ischemia in Untreated Hypertensive Patients: Effect of a Single Small Oral Dose of a Beta‐Adrenergic Blocking Agent , 1988, Anesthesiology.
[2] W. Daggett,et al. Cardiovascular response to large doses of intravenous morphine in man. , 1969, The New England journal of medicine.
[3] E. M. Papper,et al. Pharmacologic and physiologic aspects of anesthesiology. , 1970, The New England journal of medicine.
[4] S. Reiz,et al. Isoflurane—A Powerful Coronary Vasodilator in Patients with Coronary Artery Disease , 1983, Anesthesiology.
[5] M. Joyner,et al. Blood Substitutes: Fluids, Drugs, or Miracle Solutions? , 1996, Anesthesia and analgesia.
[6] Andrew D. Rosenberg,et al. Practice Guidelines for Blood Component Therapy: A Report by the American Society of Anesthesiologists Task Force on Blood Component Therapy , 1996, Anesthesiology.
[7] P. Duvaldestin,et al. Intubating conditions following 1R CIS, 1′R CIS atracurium (51W89) , 1995, Anaesthesia.
[8] H. H. Ali,et al. Histamine-releasing potencies of atracurium, dimethyl tubocurarine and tubocurarine. , 1983, British journal of anaesthesia.
[9] G. Gronert,et al. Intractable cardiac arrest in children given succinylcholine. , 1992, Anesthesiology.
[10] M. Sussman,et al. Anesthesia-induced rhabdomyolysis in a patient with Duchenne's muscular dystrophy. , 1978, Anesthesiology.
[11] B. Hindman,et al. A Prospective, Comparative Trial of Three Anesthetics for Elective Supratentorial Craniotomy: Propofol/Fentanyl, Isoflurane/Nitrous Oxide, and Fentanyl/Nitrous Oxide , 1993, Anesthesiology.
[12] L. Fleisher,et al. Relationship between postoperative anemia and cardiac morbidity in high‐risk vascular patients in the intensive care unit , 1993, Critical care medicine.
[13] D. Silverman,et al. Intraoperative use of muscle relaxants , 1993 .
[14] W. Bowman,et al. Effects of a new neuromuscular blocking agent (Org 9426) in anaesthetized cats and pigs and in isolated nerve-muscle preparations. , 1989, British journal of anaesthesia.
[15] D. Mangano. Preoperative Risk Assessment: Many Studies, Few Solutions: Is a Cardiac Risk Assessment Paradigm Possible? , 1995, Anesthesiology.
[16] S. Fischer,et al. Development and Effectiveness of an Anesthesia Preoperative Evaluation Clinic in a Teaching Hospital , 1996, Anesthesiology.
[17] P. Foëx,et al. Studies of anaesthesia in relation to hypertension. I. Cardiovascular responses of treated and untreated patients. , 1971, British journal of anaesthesia.
[18] T. Rao,et al. Reinfarction Following Anesthesia in Patients with Myocardial Infarction , 1983, Anesthesiology.
[19] S. Cotev,et al. Importance of long-duration postoperative ST-segment depression in cardiac morbidity after vascular surgery , 1993, The Lancet.
[20] A. Localio,et al. A Clinical Grading Scale to Predict Malignant Hyperthermia Susceptibility , 1994, Anesthesiology.
[21] J. Gross,et al. Propofol Depresses the Hypoxic Ventilatory Response during Conscious Sedation and Isohypercapnia , 1993, Anesthesiology.
[22] J. Hunter,et al. Comparison of the pharmacodynamics and pharmacokinetics of an infusion of cis-atracurium (51W89) or atracurium in critically ill patients undergoing mechanical ventilation in an intensive therapy unit. , 1996, British journal of anaesthesia.
[23] A. Muñoz,et al. The declining risk of post-transfusion hepatitis C virus infection. , 1992, The New England journal of medicine.
[24] R. Miller,et al. Clinical Pharmacology of Vecuronium and Atracurium , 1984, Anesthesiology.
[25] R. Prielipp,et al. Prolonged weakness after infusion of atracurium in two intensive care unit patients. , 1994, Anesthesia and analgesia.
[26] D. Silverman,et al. Pulse Width, Stimulus Intensity, Electrode Placement, and Polarity during Assessment of Neuromuscular Block , 1995, Anesthesiology.
[27] E. Eger,et al. The Cardiovascular Effects of a New Inhalation Anesthetic, Forane, in Human Volunteers at Constant Arterial Carbon Dioxide Tension , 1971, Anesthesiology.
[28] E. Eger,et al. Toxicity of Compound A in Rats: Effect of a 3‐Hour Administration , 1994, Anesthesiology.
[29] Shiv k. Sharma,et al. A Comparison of 26-G Atraucan Spinal Needles with 25-G Whitacre Needles , 1994 .
[30] E. Eger,et al. Toxicity of Compound A in Rats: Effect of Increasing Duration of Administration , 1994, Anesthesiology.
[31] M. Matthay,et al. Persistent paralysis in critically ill patients after long-term administration of vecuronium. , 1992, The New England journal of medicine.
[32] E. Eger,et al. Polyhalogenated and perfluorinated compounds that disobey the Meyer-Overton hypothesis. , 1994, Anesthesia and analgesia.
[33] T. Higgins,et al. Propofol versus midazolam for intensive care unit sedation after coronary artery bypass grafting , 1994, Critical care medicine.
[34] A. Levy,et al. Value of routine preoperative chest x-rays: a meta-analysis , 1993, Canadian journal of anaesthesia = Journal canadien d'anesthesie.
[36] E. Delphin,et al. Use of succinylcholine during elective pediatric anesthesia should be reevaluated. , 1987, Anesthesia and analgesia.
[37] H. H. Ali,et al. The Clinical Neuromuscular Pharmacology of Mivacurium Chloride (BW B1090U). A Short‐acting Nondepolarizing Ester Neuromuscular Blocking Drug , 1988, Anesthesiology.
[38] Timothy M. Williams,et al. Steal‐Prone Coronary Anatomy and Myocardial Ischemia Associated With Four Primary Anesthetic Agents in Humans , 1991, Anesthesia and analgesia.
[39] E. Eger,et al. Decreasing Enflurane Concentrations and d‐Tubocurarine Neuromuscular Blockade , 1982, Anesthesiology.
[40] T. A. Bowdle. Myoclonus following sufentanil without EEG seizure activity. , 1987, Anesthesiology.
[41] J. Seltzer,et al. Clinical Pharmacology of Pipecuronium Bromide , 1989, Anesthesia and analgesia.
[42] G. Harrison. Control of the malignant hyperpyrexic syndrome in MHS swine by dantrolene sodium. , 1975, British journal of anaesthesia.
[43] T. Ebert,et al. Desflurane-mediated Neurocirculatory Activation in Humans: Effects of Concentration and Rate of Change on Responses , 1996, Anesthesiology.
[44] J. McGill,et al. Perioperative Management of Surgical Patients with Diabetes Mellitus , 1991, Anesthesiology.
[45] D. R. Cook,et al. In vitro degradation of atracurium in human plasma. , 1985, British journal of anaesthesia.
[46] Ronald M. Jones,et al. The organ toxicity of inhaled anesthetics. , 1995, Anesthesia and analgesia.
[47] L. Fleisher,et al. The predictive value of preoperative silent ischemia for postoperative ischemic cardiac events in vascular and nonvascular surgery patients. , 1991, American heart journal.
[48] D. S. Savage,et al. The Emergence of ORG NC 45, 1- [(2β,3α, 5α,16β, 17β)-3, 17-BIS(Acetyloxy)-2-(1-Piperidinyl)-Androstan-16-YL]-1-Methylpiperidinium Bromide, from the Pancuronium Series , 1980 .
[49] J. Gold,et al. Surveillance for postoperative myocardial infarction after noncardiac operations. , 1988, Surgery, gynecology & obstetrics.
[50] D M Perrotta,et al. Postoperative infections traced to contamination of an intravenous anesthetic, propofol. , 1995, The New England journal of medicine.
[51] M. Wolff,et al. Severe sepsis after intravenous injection of contaminated propofol. , 1994, Anesthesiology.
[52] P. Sebel,et al. Propofol: A New Intravenous Anesthetic , 1989, Anesthesiology.
[53] Y. Ogasawara,et al. Reaction of sevoflurane and its degradation products with soda lime. Toxicity of the byproducts. , 1992, Anesthesiology.
[54] J. Hunter,et al. Pharmacokinetics of 1R-cis 1'R-cis atracurium besylate (51W89) and plasma laudanosine concentrations in health and chronic renal failure. , 1995, British journal of anaesthesia.
[55] G. A. Rooke,et al. Postoperative myoclonus and rigidity after anesthesia with opioids. , 1994, Anesthesia and analgesia.
[56] G. Koren,et al. FENTANYL ANESTHESIA FOR CARDIAC SURGERY IN CHILDRENa) FENTANYL-OXYGEN VS FENTANYL-N2O; b) RELATIONSHIP BETWEEN DRUG CONCENTRATIONS AND PHARMACODYNAMICS , 1984 .
[57] J. Divatia,et al. Omission of Nitrous Oxide during Anesthesia Reduces the Incidence of Postoperative Nausea and Vomiting: A Meta-Analysis , 1996, Anesthesiology.
[58] W. R. Lieb,et al. Molecular and cellular mechanisms of general anaesthesia , 1994, Nature.
[59] N. Goodman,et al. Haemodynamic effects of infusions of diisopropyl phenol (ICI 35 868) during nitrous oxide anaesthesia in man. , 1983, British journal of anaesthesia.
[60] E. Eger,et al. Anesthetic potencies of sulfur hexafluoride, carbon tetrafluoride, chloroform and Ethrane in dogs: correlation with the hydrate and lipid theories of anesthetic action. , 1969, Anesthesiology.
[61] A. J. Gandolfi,et al. Adverse effects of volatile anaesthetics. , 1987, British journal of anaesthesia.
[62] J. Janosky,et al. Opioid Neurotoxicity: Neuropathologic Effects in Rats of Different Fentanyl Congeners and the Effects of Hexamethonium-Induced Normotension , 1996, Anesthesia and analgesia.
[63] B. Chaitman,et al. Preoperative clinical assessment and dipyridamole thallium-201 scintigraphy for prediction and prevention of cardiac events in patients having major noncardiovascular surgery and known or suspected coronary artery disease. , 1994, The American journal of cardiology.
[64] R. Glavin,et al. Comparison of midazolam with propofol for sedation in outpatient bronchoscopy. , 1993, British journal of anaesthesia.
[65] J. Wierda,et al. Clinical pharmacology of rocuronium (Org 9426): study of the time course of action, dose requirement, reversibility, and pharmacokinetics. , 1994, Journal of clinical anesthesia.
[66] P. White,et al. Propofol: An update on its Clinical Use , 1994, Anesthesiology.
[67] G. Scheiber,et al. Deep sedation with propofol in preschool children undergoing radiation therapy , 1996, Paediatric anaesthesia.
[68] J. Hartung. Twenty-Four of Twenty-Seven Studies Show a Greater Incidence of Emesis Associated with Nitrous Oxide than with Alternative Anesthetics , 1996, Anesthesia and analgesia.
[69] L. Fleisher,et al. Preoperative Dipyridamole Thallium Imaging and Ambulatory Electrocardiographic Monitoring as a Predictor of Perioperative Cardiac Events and Long‐term Outcome , 1995, Anesthesiology.
[70] E. Eger,et al. Decreasing Enflurane Concentrations and d-Tubocurarine Neuromuscular Blockade , 1982 .
[71] D. Mangano,et al. The risk of myocardial ischemia in patients receiving desflurane versus sufentanil anesthesia for coronary artery bypass graft surgery. The S.P.I. Research Group. , 1992, Anesthesiology.
[72] A. Jaffe,et al. Diagnosis of perioperative myocardial infarction with measurement of cardiac troponin I. , 1994, The New England journal of medicine.
[73] M. Barrios,et al. Comparative study of propofol versus midazolam in the sedation of critically ill patients: results of a prospective, randomized, multicenter trial. , 1996, Critical care medicine.
[74] K. Davis,et al. The Prevalence of Steal‐prone Coronary Anatomy in Patients with Coronary Artery Disease: An Analysis of the Coronary Artery Surgery Study Registry , 1988, Anesthesiology.
[75] Eger Ei nd. Desflurane animal and human pharmacology: aspects of kinetics, safety, and MAC. , 1992 .
[76] N. Obuchowski,et al. Intravenous sedation for MR imaging of the brain and spine in children: pentobarbital versus propofol. , 1993, Radiology.
[77] Jeffery Vender,et al. Comparison of the Infusion Requirements and Recovery Profiles of Vecuronium and Cisatracurium 51W89 in Intensive Care Unit Patients , 1995, Anesthesia and analgesia.
[78] B. Thompson,et al. Nuclear cardiac ejection fraction and cardiac index in abdominal aortic surgery. , 1983, Surgery.
[79] A. J. Gandolfi,et al. Plasma inorganic fluoride with sevoflurane anesthesia: correlation with indices of hepatic and renal function. , 1992 .
[80] P. Suter,et al. Adjuvant propofol enables better control of nausea and emesis secondary to chemotherapy for breast cancer , 1994, Canadian journal of anaesthesia = Journal canadien d'anesthesie.
[81] F. Freund,et al. Abdominal-muscle rigidity induced by morphine and nitrous oxide. , 1973, Anesthesiology.
[82] F. Foldes,et al. Succinylcholine: a new approach to muscular relaxation in anesthesiology. , 1952, The New England journal of medicine.
[83] H. Van Aken,et al. Remifentanil: A Novel, Short-Acting, mu-Opioid , 1996, Anesthesia and analgesia.
[84] R. Hughes,et al. The pharmacology of atracurium: a new competitive neuromuscular blocking agent. , 1981, British Journal of Anaesthesia.
[85] R. P. Cochran,et al. Perfluorocarbon emulsions and cardiopulmonary bypass: a technique for the future. , 1996, Journal of cardiothoracic and vascular anesthesia.
[86] E. Keeler,et al. RAND Corporation From the SelectedWorks of Emmett Keeler March , 1995 The Cost Effectiveness of Preoperative Autologous Blood Donations , 2016 .
[87] W. Taylor,et al. Myocardial infarction after general anesthesia. , 1973, Anesthesia and analgesia.